Chlamydia

Vaccines for Biodefense and Emerging and Neglected Diseases

Volumn , Issue , 2008, Pages 845-867

  Rank, Roger G ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84858975623     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-369408-9.00044-5     Document Type: Chapter

References (130)

1. M.D. Alani, S. Darougar, D.C. Burns, R.N. Thin and H. Dunn (1977) Isolation of Chlamydia trachomatis from the male urethra. Br. J. Vener. Dis. 53 88-92
2. J.N. Arno, B.P. Katz, R. McBride, G.A. Carty, B.E. Batteiger, V.A. Caine and R.B. Jones (1994) Age and clinical immunity to infections with Chlamydia trachomatis. Sex. Transm. Dis. 21 47-52
3. J. Barenfanger and A.B. MacDonald (1974) The role of immunoglobulin in the neutralization of trachoma infectivity. J. Immunol. 113 1607-1617
4. B.E. Batteiger, R.G. Rank, P.M. Bavoil and L.S.F. Soderberg (1993) Partial protection against reinfection by immunization of guinea pigs with isolated outer-membrane proteins of the chlamydial agent of guinea pig inclusion conjunctivitis. J. Gen. Microbiol. 139 2965-2972
5. P. Bavoil, A. Ohlin and J. Schachter (1984) Role of disulfide bonding in outer membrane structure and permeability in Chlamydia trachomatis. Infect. Immun. 44 479-485
6. P.B. Bavoil and P.B. Wyrick (2006) Note from the editors. P.M. Bavoil, P.B. Wyrick,(Eds) Chlamydia: Genomics and Pathogenesis Norfolk, UK: Horizon Bioscience
7. S.P. Bedson (1953) The psittacosis-lymphogranuloma venereum group of viruses. Br. Med. Bull. 9 226
8. G. Bietti and G.H. Werner (1967) Trachoma: Prevention and Treatment. Springfield, IL: Charles C. Thomas
9. R.C. Brunham, C.-C. Kuo, L. Cles and K.K. Holmes (1983) Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect. Immun. 39 1491-1494
10. R.C. Brunham, I.W. Maclean, B. Binns and R.W. Peeling (1985) Chlamydia trachomatis: its role in tubal infertility. J. Infect. Dis. 152 1275-1282
11. R.C. Brunham, R. Peeling, I. Maclean, J. McDowell, K. Persson and S. Osser (1987) Postabortal Chlamydia trachomatis salpingitis: correlating risk with antigen-specific serological responses and with neutralization. J. Infect. Dis. 155 749-755
12. T.K. Cain and R.G. Rank (1995) Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect. Immun. 63(5), 1784-1789
13. H.D. Caldwell, J. Kromhout and J. Schachter (1981) Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect. Immun. 31 1161-1176
14. H.D. Caldwell, C.C. Kuo and G.E. Kenny (1975) Antigenic analysis of Chlamydiae by two dimensional immunoelectrophoresis. I. Antigenic heterogeneity between C. trachomatis and C. psittaci. J. Immunol. 115 963-968
15. H.D. Caldwell and L.J. Perry (1982) Neutralization of Chlamydia trachomatis infectivity with antibodies to the major outer membrane protein. Infect. Immun. 38 745-754
16. L.H. Collier and W.A. Blyth (1966) Immunogenicity of experimental trachoma vaccines in baboons. I. Experimental methods, and preliminary tests with vaccines prepared in chick embryos and in HeLa cells. J. Hyg. (Camb.) 64 513-528
17. L.H. Collier and W.A. Blyth (1966) Immunogenicity of experimental trachoma vaccines in baboons. II. Experiments with adjuvants, and tests of cross-protection. J. Hyg. (Camb.) 64 529-544
18. L.H. Collier and W.A. Blyth (1967) Immunogenicity of experimental trachoma vaccines in baboons. III. Experiments with inactivated vaccines. J. Hyg. (Camb.) 65 97-107
19. L.H. Collier and A.E.N.S. Mogg (1969) Dissemination and immunogenicity of live TRIC agent in baboons after parenteral injection. II. Experiments with a ‘slow-killing’ strain. J. Hyg. 67 449-455
20. L.H. Collier and A. Smith (1967) Dissemination and immunogenicity of live TRIC agent in baboons after parenteral injection. Am. J. Ophthalmol. 63 1589-1602
21. T.W. Cotter, K.H. Ramsey, G.S. Miranpuri, C.E. Poulsen and G.I. Byrne (1997) Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice. Infect. Immun. 65(6), 2145-2152
22. D.D. Crane, J.H. Carlson, E.R. Fischer, P. Bavoil, R.C. Hsia, C. Tan, C.C. Kuo and H.D. Caldwell (2006) Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen. Proc. Natl. Acad. Sci. U.S.A. 103(6), 1894-1899
23. T. Darville, J.M. O’Neill, C.W. Andrews Jr., U.M. Nagarajan, L. Stahl and D.M. Ojcius (2003) Toll-Like receptor-2, but not toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J. Immunol. 171(11), 6187-6197
24. S.P. Dhir, L.P. Agarwal, R. Detels, S.-P. Wang and J.T. Grayston (1967) Field trial of two bivalent trachoma vaccines in children of Punjab Indian villages. Am. J. Ophthalmol. 63 1639-1644
25. F. Dong, Y. Zhong, B. Arulanandam and G. Zhong (2005) Production of a proteolytically active protein, chlamydial protease/proteasome-like activity factor, by five different Chlamydia species. Infect. Immun. 73(3), 1868-1872
26. F.O. Eko, Q. He, T. Brown, L. McMillan, G.O. Ifere, G.A. Ananaba, D. Lyn, W. Lubitz, K.L. Kellar, C.M. Black and J.U. Igietseme (2004) A novel recombinant multisubunit vaccine against Chlamydia. J. Immunol. 173 3375-3382
27. J.T. Grayston, K.S.W. Kim, E.R. Alexander and S.-P. Wang (1971) Protective studies in monkeys with trivalent and monovalent trachoma vaccines. R.L. Nichols,(Eds) Trachoma and Related Disorders Caused by Chlamydial Agents Amsterdam, The Netherlands: Excerpta Medica 377-385
28. J.T. Grayston, R.A. Kronmal, L.A. Jackson, A.F. Parisi, J.B. Muhlestein, J.D. Cohen, W.J. Rogers, J.R. Crouse, S.L. Borrowdale, E. Schron and C. Knirsch ACES Investigators (2005) Azithromycin for the secondary prevention of coronary events. N. Engl. J. Med. 352(16), 1637-1645
29. J.T. Grayston and S.-P. Wang (1975) New knowledge of chlamydiae and the diseases they cause. J. Infect. Dis. 132 87-105
30. J.T. Grayston, S.-P. Wang, H.M. Lin, F.H. Tai, O.K. Khaw and R.L. Woolridge (1961) Trachoma vaccine studies in volunteer students of the National Defense Medical Center. Chin. Med. J. (Engl.) 8 312-318
31. J.T. Grayston, R.L. Woolridge, S. Wang, C. Yen, C. Yang, K. Cheng and I. Chang (1963) Field studies of protection from infection by experimental trachoma virus vaccine in preschool-aged children on Taiwan. Proc. Soc. Exp. Biol. Med. 112 589-595
32. L. Halberstaedter and S. von Prowazek (1907) Ueber Zelleinschluesse parasitaerer Nature bein Trachom. Arb. Gesundhetisa. 26 44-47
33. L. Halberstaedter and S. von Prowazek (1909) Über Chlamydozoenbefunde bei Blennorrhoea neonatorum non gonorrhoica. Klin. Wochenschr. 46 1839-1840
34. R.A. Hawkins, R.G. Rank and K.A. Kelly (2002) A Chlamydia trachomatis-specific Th2 clone does not provide protection against a genital infection and displays reduced trafficking to the infected genital mucosa. Infect. Immun. 70(9), 5132-5139
35. B. Heymann (1910) Ueber die Fundorte der Prowazek’schen Koerperchen. Berl. Klin. Wochenschr. 47 663-666
36. M.J. Holland, R.L. Bailey, D.J. Conway, F. Culley, G. Miranpuri, G.I. Byrne, H.C. Whittle and D.C.W. Mabey (1996) T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC); Responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring. Clin. Exp. Immunol. 105(3), 429-435
37. R.-C. Hsia, Y. Pannekoek, E. Ingerowshi and P.M. Bavoil (1997) Type III secretion genes identify a putative virulence locus of Chlamydia. Mol. Microbiol. 25(2), 351-359
38. J.U. Igietseme, D.M. Magee, D.M. Williams and R.G. Rank (1994) Role for CD8 + T cells in antichlamydial immunity defined by chlamydia-specific T-lymphocyte clones. Infect. Immun. 62 5195-5197
39. J.U. Igietseme, K.H. Ramsey, D.M. Magee, D.M. Williams, T.J. Kincy and R.G. Rank (1993) Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific TH1 lymphocyte clone. Reg. Immunol. 5 317-324
40. J.U. Igietseme and R.G. Rank (1991) Susceptibility to reinfection after a primary chlamydial genital infection is associated with a decrease of antigen-specific T cells in the genital tract. Infect. Immun. 59 1346-1351
41. B.R. Jones (1964) Ocular syndromes of TRIC virus infection and their possible genital significance. Br. J. Vener. Dis. 40 3-18
42. B.R. Jones, L.H. Collier and C.H. Smith (1959) Isolation of virus from inclusion blennorrhea. Lancet 1 902-905
43. R.B. Jones, B.E. Batteiger (1986) Human immune response to Chlamydia trachomatis infections. J. Oriel, et al., (Eds) Chlamydial Infections London, UK: Cambridge University Press 423-432
44. R.B. Jones, B. Van der Pol (1994) Lack of correlation between acquisition of infection and ability of serum to neutralize chlamydial infectivity in vitro. J. Orfila, et al., (Eds) Chlamydial Infections Bologna, Italy: Societa Editrice Esculapio 95-98
45. B.P. Katz, B.E. Batteiger and R.B. Jones (1987) Effect of prior sexually transmitted disease on the isolation of Chlamydia trachomatis. Sex. Transm. Dis. 14 160-164
46. D.E. Kawa, J. Schachter and R.S. Stephens (2004) Immune response to the Chlamydia trachomatis outer membrane protein PorB. Vaccine 22(31–32), 4282-4286
47. D.E. Kawa and R.S. Stephens (2002) Antigenic topology of Chlamydial PorB protein and identification of targets for immune neutralization of infectivity. J. Immunol. 168(10), 5184-5191
48. K.A. Kelly and R.G. Rank (1997) Identification of homing receptors that mediate the recruitment of CD4 T cells to the genital tract following intravaginal infection with Chlamydia trachomatis. Infect. Immun. 65 5198-5208
49. K.A. Kelly, E.A. Robinson and R.G. Rank (1996) Identification of cell adhesion molecules that mediate CD4 lymphocyte homing to the genital tract mucosa during infection with mouse pneumonitis biovar of Chlamydia trachomatis. A. Stary,(Eds) Chlamydia Research Vol. 3 Bologna, Italy: Societa Editrice Esculapio 76
50. J. Kimani, I.W. Maclean, J.J. Bwayo, K. MacDonald, J. Oyugi, G.M. Maitha, R.W. Peeling, M. Cheang, N.J. Nagelkerke, F.A. Plummer and R.C. Brunham (1996) Risk factors for Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi, Kenya. J. Infect. Dis. 173(6), 1437-1444
51. T. Kroner (1884) Zur Ätiologie der Ophthalmoblennorrhoea neonatorum. Zentralbl. Gynaekol. 8 643-645
52. C.Y. Lau and A.K. Qureshi (2002) Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex. Transm. Dis. 29(9), 497-502
53. R. Malaty, C.R. Dawson, I. Wong, C. Lyon and J. Schachter (1981) Serum and tear antibodies to Chlamydia after reinfection with guinea pig inclusion conjunctivitis agent. Invest. Ophthalmol. Vis. Sci. 21 833-841
54. P.A. Mardh, T. Ripa, L. Svensson and L. Westrom (1977) Chlamydia trachomatis infection in patients with acute salpingitis. N. Engl. J. Med. 296 1377-1379
55. P.L. Masson, J.F. Heremans and J. Ferin (1969) Clinical importance of the biochemical changes in the female genital tract. I. Studies on the proteins of cervical mucus. Int. J. Fertil. 14 1-7
56. W.C. Miller, C.A. Ford, M. Morris, M.S. Handcock, J.L. Schmitz, M.M. Hobbs, M.S. Cohen, K.M. Harris and J.R. Udry (2004) Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 291(18), 2229-2236
57. F. Modabber, S.E. Bear and J. Cerny (1976) The effect of cyclophosphamide on the recovery from a local chlamydial infection. Guinea pig inclusion conjunctivitis. Immunol. 30 929-933
58. M.A. Monnickendam, S. Darougar, J.D. Treharne and A.M. Tilbury (1980) Development of chronic conjunctivitis with scarring and pannus, resembling trachoma, in guinea pigs. Br. J. Ophthalmol. 64 284-290
59. M.A. Monnickendam, S. Darougar, J.D. Treharne and A.M. Tilbury (1980) Guinea pig inclusion conjunctivitis as a model for the study of trachoma: clinical, microbiological, serological, and cytological studies of primary infection. Br. J. Ophthalmol. 64 279-283
60. R.P. Morrison (1991) Chlamydial hsp60 and the immunopathogenesis of chlamydial disease. Semin. Immunol. 3 25-33
61. R.P. Morrison, R.J. Belland, K. Lyng and H.D. Caldwell (1989) Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein. J. Exp. Med. 170 1271-1283
62. R.P. Morrison, K. Feilzer and D.B. Tumas (1995) Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect. Immun. 63(12), 4661-4668
63. S.G. Morrison and R.P. Morrison (2005) A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection. J. Immunol. 175(11), 7536-7542
64. S.G. Morrison and R.P. Morrison (2005) A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection. J. Immunol. 175(11), 7536-7542
65. S.G. Morrison, H. Su, H.D. Caldwell and R.P. Morrison (2000) Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells. Infect. Immun. 68(12), 6979-6987
66. J.W. Moulder, T.P. Hatch, C.-C. Kuo, J. Schachter and J. Storz (1984) Genus Chlamydia. N.R. Krieg,(Eds) Bergey’s Manual of Systematic Bacteriology Baltimore, MD: Williams & Wilkins 729-739
67. A.K. Murthy, J.P. Chambers, P.A. Meier, G. Zhong and B.P. Arulanandam (2007) Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production. Infect. Immun. 75(2), 666-676
68. D.E. Nelson, D.P. Virok, H. Wood, C. Roshick, R.M. Johnson, W.M. Whitmire, D.D. Crane, O. Steele-Mortimer, L. Kari, G. McClarty and H.D. Caldwell (2005) Chlamydial IFN-{gamma} immune evasion is linked to host infection tropism. Proc. Natl Acad. Sci. 102(30), 10658-10663
69. R.L. Nichols, S.D. Bell Jr., N.A. Haddad and A.A. Bobb (1969) Studies on trachoma VI. Microbiological observations in a field trial in Saudi Arabia of bivalent trachoma vaccine at three dosage levels. Am. J. Trop. Med. Hyg. 18 723-730
70. R.L. Nichols, S.D. Bell Jr., E.S. Murray, N.A. Haddad and A.A. Bobb (1966) Studies on trachoma. V. Clinical observations in a field trial of bivalent trachoma vaccine at three dosage levels in Saudi Arabia. Am. J. Trop. Med. Hyg. 15 639-647
71. R.L. Nichols, R.E. Oertley, C.E.O. Fraser, A.B. MacDonald and D.E. McComb (1973) Immunity to chlamydial infections of the eye. VI. Homologous neutralization of trachoma infectivity for the owl monkey conjunctivae by eye secretions from humans with trachoma. J. Infect. Dis. 127 429-432
72. M. Nurminen, E. Wahlstrom, M. Kleemola, M. Leinonen, P. Saikku and P.H. Makela (1984) Immunologically related ketodeoxyoctonate containing structures in Chlamydia trachomatis, Re:mutants of Salmonella species, and Acinetobacter calcoaceticus var. anitratus. Infect. Immun. 44 609-613
73. C.M. O’connell, R.R. Ingalls, C.W. Andrews Jr., A.M. Scurlock and T. Darville (2007) Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease. J. Immunol. 179(6), 4027-4034
74. Pal, S., Peterson, E.M., Rappuoli, R., Ratti, G. and de la Maza, L.M. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge. Vaccine 2006; 24 6:766–775
75. S. Pal, I. Theodor, E.M. Peterson and L.M. de la Maza (1997) Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge. Infect. Immun. 65(8), 3361-3369
76. J.H. Pearce, I. Allan and S. Ainsworth (1981) Interaction of chlamydiae with host cells and mucous surfaces. Ciba Found. Symp. 80 234-251
77. L.L. Perry, K. Feilzer and H.D. Caldwell (1997) Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways. J. Immunol. 158 3344-3352
78. K.H. Ramsey, W.J. Newhall and R.G. Rank (1989) Humoral immune response to chlamydial genital infection of mice with the agent of mouse pneumonitis. Infect. Immun. 57 2441-2446
79. K.H. Ramsey, R.G. Rank (1990) The role of T cell subpopulations in resolution of chlamydial genital infection of mice. W.R. Bowie, et al., (Eds) Chlamydial Infections New York, NY: Cambridge University Press 241-244
80. K.H. Ramsey, I.M. Sigar, J.H. Schripsema, N. Shaba and K.P. Cohoon (2005) Expression of matrix metalloproteinases subsequent to urogenital Chlamydia muridarum infection of mice. Infect. Immun. 73(10), 6962-6973
81. K.H. Ramsey, L.S.F. Soderberg and R.G. Rank (1988) Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection. Infect. Immun. 56 1320-1325
82. R.G. Rank (1999) Models of immunity. R.S. Stephens,(Eds) Chlamydia: Intracellular Biology, Pathogenesis, and Immunity Washington, D.C.: American Society for Microbiology 239-295
83. R.G. Rank and A.L. Barron (1983) Effect of antithymocyte serum on the course of chlamydial genital infection in female guinea pigs. Infect. Immun. 41 876-879
84. R.G. Rank and A.L. Barron (1983) Humoral immune response in acquired immunity to chlamydial genital infection of female guinea pigs. Infect. Immun. 39 463-465
85. R.G. Rank and B.E. Batteiger (1989) Protective role of serum antibody in immunity to chlamydial genital infection. Infect. Immun. 57 299-301
86. R.G. Rank, B.E. Batteiger and L.S.F. Soderberg (1988) Susceptibility to reinfection after a primary chlamydial genital infection. Infect. Immun. 56 2243-2249
87. R.G. Rank, A.K. Bowlin, R.L. Reed and T. Darville (2003) Characterization of chlamydial genital infection resulting from sexual transmission from male to female guinea pigs and determination of infectious dose. Infect. Immun. 71(11), 6148-6154
88. Rank, R.G., Dascher, C., Bowlin, A.K. and Bavoil, P.M. Systemic immunization with HSP60 alters the development of Chlamydial ocular disease. Invest. Ophthalmol. Vis. Sci. 1995; 36 7:1344–1351
89. R.G. Rank and M.M. Sanders (1992) Pathogenesis of endometritis and salpingitis in a guinea pig model of chlamydial genital infection. Am. J. Pathol. 140 927-936
90. R.G. Rank, M.M. Sanders and D.L. Patton (1995) Increased incidence of oviduct pathology in the guinea pig after repeat vaginal inoculation with the chlamydial agent of guinea pig inclusion conjunctivitis. J. Sex. Transm. Dis. 22(1), 48-54
91. R.G. Rank, L.S.F. Soderberg and A.L. Barron (1985) Chronic chlamydial genital infection in congenitally athymic nude mice. Infect. Immun. 48 847-849
92. R.G. Rank, L.S.F. Soderberg, M.M. Sanders and B.E. Batteiger (1989) Role of cell-mediated immunity in the resolution of secondary chlamydial genital infection in guinea pigs infected with the agent of guinea pig inclusion conjunctivitis. Infect. Immun. 57 706-710
93. R.G. Rank, H.J. White and A.L. Barron (1979) Humoral immunity in the resolution of genital infection in female guinea pigs infected with the agent of guinea pig inclusion conjunctivitis. Infect. Immun. 26 573-579
94. S.J. Rasmussen, L. Eckmann, A.J. Quayle, L. Shen, Y.X. Zhang, D.J. Anderson, J. Fierer, R.S. Stephens and M.F. Kagnoff (1997) Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J. Clin. Invest. 99(1), 77-87
95. Rasmussen, S.J., Sen, C.K. and Stephens, R.S. Temporal expression of interleukin-8 in Chlamydia-infected epithelial cells. In: Proceedings of the Ninth International Symposium on Human Chlamydial Infection (R.S. Stephens et al., Eds.), pp. 411–414. San Francisco: International Chlamydia Symposium, 1998
96. A. Rodolakis and F. Bernard (1984) Vaccination with temperature sensitive mutant of Chlamydia psittaci against enzootic abortion of ewes. Vet. Rec. 114 193-194
97. A. Rodolakis and A. Souriau (1983) Response of ewes to temperature sensitive mutants of Chlamydia psittaci (var.ovis) obtained by NTG mutagenesis. Ann. Rech. Vet. 14 155-161
98. J. Schachter, L.D. Cles, R.M. Ray and F.E. Hesse (1983) Is there immunity to chlamydial infections of the human genital tract? Sex. Transm. Dis. 10 123-125
99. J. Schachter and C.R. Dawson (1978) Human Chlamydial Infections. Littleton, MA: PSG Publishing Company
100. S. Sowa, J. Sowa, L.H. Collier and W.A. Blyth (1969) Trachoma field trials in The Gambia. J. Hyg. 67 699-717
101. R.S. Stephens (2003) The cellular paradigm of chlamydial pathogenesis. Trends Microbiol. 11 44-51
102. R.S. Stephens, E.A. Wagar and G.K. Schoolnik (1988) High-resolution mapping of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis. J. Exp. Med. 167 817-831
103. H. Su and H.D. Caldwell (1995) CD4 + T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract. Infect. Immun. 63(9), 3302-3308
104. H. Su, K. Feilzer, H.D. Caldwell and R.P. Morrison (1997) Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect. Immun. 65(6), 1993-1999
105. H. Su, R. Messer, W. Whitmore, E. Fischer, J.C. Portis and H.D. Caldwell (1998) Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable chlamydiae. J. Exp. Med. 188(5), 809-818
106. F.F. T’ang, H.L. Chang, Y.T. Huang and K.C. Wang (1957) Studies on the etiology of trachoma with special reference to isolation of the virus in chick embryo. Chin. Med. J. (Peking) 75 429-446
107. M.A. Tanner, J.K. Harris and N.R. Pace (1999) Molecular phylogeny of Chlamydia and relatives. R.S. Stephens,(Eds) Chlamydia: Intracellular Biology, Pathogenesis, and Immunity Washington, D.C.: American Society for Microbiology 1-8
108. H.R. Taylor (1985) Ocular models of chlamydial infection. Rev. Infect. Dis. 7 737-740
109. H.R. Taylor, S.L. Johnson, R.A. Prendergast, J. Schachter, C.R. Dawson and A.M. Silverstein (1982) An animal model of trachoma II. The importance of repeated reinfection. Invest. Ophthalmol. Vis. Sci. 23 507-515
110. H.R. Taylor, R.A. Prendergast, C.R. Dawson, J. Schachter and A.M. Silverstein (1981) An animal model for cicatrizing trachoma. Invest. Ophthalmol. Vis. Sci. 21 422-433
111. P. Thygeson (1962) Trachoma virus: historical background and review of isolates. Ann. N. Y. Acad. Sci. 98 6-13
112. C.K. Tseng and R.G. Rank (1998) Role of NK cells in the early host response to chlamydial genital infection. Infect. Immun. 66(12), 5867-5875
113. M. Tuffrey, F. Alexander and D. Taylor-Robinson (1990) Severity of salpingitis in mice after primary and repeated inoculation with a human strain of Chlamydia trachomatis. J. Exp. Pathol. 71 403-410
114. W.C. Van Voorhis, L.K. Barrett, Y.T.C. Sweeney, C.C. Kuo and D.L. Patton (1996) Analysis of lymphocyte phenotype and cytokine activity in the inflammatory infiltrates of the upper genital tract of female macaques infected with Chlamydia trachomatis. J. Infect. Dis. 174(3), 647-650
115. E.A. Wagar, J. Schachter, P. Bavoil and R.S. Stephens (1990) Differential human serologic response to two 60,000 molecular weight Chlamydia trachomatis antigens. J. Infect. Dis. 162 922-927
116. S.-P. Wang and J.T. Grayston (1967) Pannus with experimental trachoma and inclusion conjunctivitis agent infection of Taiwan monkeys. Am. J. Ophthalmol. 63 1133-1145
117. S.-P. Wang and J.T. Grayston (1971) Studies on the identity of the ‘fast’ egg-killing chlamydia strains. R.L. Nichols,(Eds) Trachoma and Related Disorders Caused by Chlamydial Agents Amsterdam, The Netherlands: Excerpta Medica 322-336
118. S.-P. Wang and J.T. Grayston (1971) Classification of TRIC and related strains with microimmunofluorescence. R.L. Nichols,(Eds) Trachoma and Related Disorders Caused by Chlamydial Agents Excerpta Medica 305-321
119. S.P. Wang, J.T. Grayston and E.R. Alexander (1967) Trachoma vaccine studies in monkeys. Am. J. Ophthalmol. 63 1615-1630
120. H. Weinstock, D. Dean and G. Bolan (1994) Chlamydia trachomatis infections. Infect. Dis. Clin. North Am. 4 797-819
121. J.A. Whittum-Hudson, H.R. Taylor, M. Farazdaghi and R.A. Prendergast (1986) Immunohistochemical study of the local inflammatory response to chlamydial ocular infection. Invest. Ophthalmol. Vis. Sci. 27 64-69
122. D.M. Williams, J. Schachter, M.H. Weiner and B. Grubbs (1984) Antibody in host defense against mouse pneumonitis agent (murine Chlamydia trachomatis). Infect. Immun. 45 674-678
123. P. Wolner-Hanssen, D.L. Patton and K.K. Holmes (1991) Protective immunity in pig-tailed macaques after cervical infection with Chlamydia trachomatis. Sex. Transm. Dis. 18 21-25
124. P. Wolner-Hanssen, D.L. Patton, W.E. Stamm, K.K. Holmes (1986) Severe salpingitis in pig-tailed macaques after repeated cervical infections followed by a single tubal inoculation with Chlamydia trachomatis. D. Oriel, et al., (Eds) Chlamydia Infections New York, NY: Cambridge University Press 371-374
125. R.L. Woolridge, J.T. Grayston, I.H. Chang, C.Y. Yang and K.H. Cheng (1967) Field trial of a monovalent and of a bivalent mineral oil adjuvant trachoma vaccine in Taiwan school children. Am. J. Ophthalmol. 63 1645-1650
126. R.L. Woolridge, J.T. Grayston, I.H. Chang, C.Y. Yang and K.H. Cheng (1967) Long-term follow-up of the initial (1959–1960) trachoma vaccine field trial on Taiwan. Am. J. Ophthalmol. 63 1650-1653
127. Workowski, K.A. and Berman, S.M. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm. Rep. 2006; 55:1–94
128. P.B. Wyrick, E.A. Brownridge and B.E. Ivins (1978) Interaction of Chlamydia psittaci with mouse peritoneal macrophages. Infect. Immun. 19 1061-1067
129. Y.-X. Zhang, S.J. Stewart and H.D. Caldwell (1989) Protective monoclonal antibodies to Chlamydia trachomatis serovar- and serogroup-specific major outer membrane protein determinants. Infect. Immun. 57 636-638
130. G. Zhong, P. Fan, H. Ji, F. Dong and Y. Huang (2001) Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J. Exp. Med. 193(8), 935-942